Supply of Magnesium Sulfate (Laxative) – Oral Granules

The contract solicits the manufacture, packaging, labeling, and delivery of Magnesium Sulfate oral granules at a concentration of 495mg per 5mL, packaged in 454g bags with twelve bags per case, specifically for supply to a deployed U.S. Navy aircraft carrier. The product is intended for use as a laxative under medical supervision in a deployed operational setting, requiring strict adherence to pharmaceutical standards for safety, stability, and consistency. All packaging and labeling must meet military and regulatory specifications to ensure proper identification, dosage accuracy, and handling under austere conditions, including durable, weather-resistant materials suitable for shipboard environments. The procurement is issued under the North American Industry Classification System code 325412, indicating pharmaceutical preparation manufacturing, and is categorized as a subcontract under the Department of Defense’s Medical Supply Chain Pharmacy FSA. The opportunity was posted on August 3, 2026, with a response deadline of August 10, 2026. Place of performance is designated as FPO 96632, reflecting delivery to a naval vessel at sea, emphasizing the critical timeline and logistics coordination required to support naval medical readiness. The contract demands end-to-end compliance from production through final delivery, with no flexibility in formulations, packaging configurations, or delivery schedules to ensure seamless integration into the deployed medical supply chain.